Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

April 30, 2004

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

carboplatin

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (18)

30659

Frauenklinik der MHH, Hanover

39108

Klinik der Otto-v.-Guericke-Universitat, Magdeburg

65929

Staedtisches Krankenhaus FFM-Hoechst, Frankfurt am Main

D-10117

Universitaetsklinikum Charite, Berlin

D-28205

Zentralkrankenhaus, Bremen

D-01307

Medizinische Klinik I, Dresden

DOH-4-0217

Evangelisches Krankenhaus, Düsseldorf

D-60590

Klinikum der J.W. Goethe Universitaet, Frankfurt

D-37075

Universitaetsklinik Goettingen, Göttingen

D-17487

Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald

D-76137

Vincentius Krankenhaus, Karlsruhe

D-24105

Christian-Albrechts University of Kiel, Kiel

D-81377

Klinikum Grosshadern, Munich (Muenchen)

D-81675

Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich (Muenchen)

D-48129

Klinik und Poliklinik fuer Kinderheilkunde, Münster

D-72076

Universitaetsklinikum Tuebingen, Tübingen

D-89075

Universitaet Ulm, Ulm

D-65199

Dr. Horst-Schmidt-Kliniken, Wiesbaden

All Listed Sponsors
lead

AGO Study Group

OTHER

NCT00031954 - Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | Biotech Hunter | Biotech Hunter